Statements (25)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
muscarinic antagonist |
| gptkbp:ATCCode |
R03BB05
|
| gptkbp:brand |
gptkb:Eklira
gptkb:Tudorza |
| gptkbp:CASNumber |
320345-99-1
|
| gptkbp:developedBy |
gptkb:Almirall
|
| gptkbp:eliminationHalfLife |
5 to 8 hours
|
| gptkbp:excretion |
urine
feces |
| gptkbp:hasMolecularFormula |
C26H30NO4S
|
| https://www.w3.org/2000/01/rdf-schema#label |
aclidinium
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
muscarinic receptor antagonist
|
| gptkbp:metabolism |
hydrolysis
|
| gptkbp:pregnancyCategory |
C (US)
|
| gptkbp:proteinBinding |
87%
|
| gptkbp:routeOfAdministration |
inhalation
|
| gptkbp:sideEffect |
headache
cough dry mouth nasopharyngitis |
| gptkbp:usedFor |
chronic obstructive pulmonary disease
|
| gptkbp:bfsParent |
gptkb:formoterol
|
| gptkbp:bfsLayer |
6
|